Earnings release · AMGN
AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
Amgen Inc. · Filed · SEC Form 8-K, Item 2.02
Revenue
$10.1 billion
+10% vs a year ago
EPS
$2.65
not detected
Guidance
—none detected
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete.
Please read the original before relying on any figure. Not investment advice.
Why it matters
Revenue grew 10% year on year to $10.1 billion, and EPS was $2.65.
Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.
What the company states
Revenue
$10.1 billion +10% vs a year ago
…For the second quarter, total revenues increased 10% to $10.1 billion in comparison to the second quar…
EPS
$2.65
…GAAP earnings per share (EPS) increased 65% from $2.65 to $4.37 for the second quarter, driven by higher revenues.…
Guidance
No guidance statement detected
Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.